Oligopeptide-34
Synthetic peptide studied in animal and cell models for multi-level melanogenesis modulation and non-cytotoxic mechanism
Last updated: March 1, 2026
- Compound
- Oligopeptide-34
- Class
- Longevity peptide
- Summary
- Synthetic peptide studied in animal and cell models for multi-level melanogenesis modulation, non-cytotoxic mechanism, comparable efficacy to established agents.
- Mechanism
- Cumulative Pigmentation Reduction
- Research Status
- Preclinical
- Routes Studied
- Topical application
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About Oligopeptide-34?
- What is Oligopeptide-34?
- Oligopeptide-34 is a synthetic peptide studied in animal and cell models for multi-level melanogenesis modulation and non-cytotoxic mechanism.
- Is Oligopeptide-34 clinically proven?
- No. Human evidence remains limited and does not establish Oligopeptide-34 as clinically proven.
- What has Oligopeptide-34 been studied for?
- Oligopeptide-34 has been studied in preclinical models of multi-level melanogenesis modulation, non-cytotoxic mechanism, comparable efficacy to established agents. These findings have not been confirmed in large-scale human trials.
- Is Oligopeptide-34 approved?
- No. Oligopeptide-34 is not an approved drug and remains a research compound.
What Is Oligopeptide-34?
Oligopeptide-34 is a synthetic bioactive peptide designed to modulate melanogenesis, the biological process by which melanocytes produce melanin pigment in the skin. Unlike traditional skin-brightening agents that rely on broad enzymatic inhibition or cytotoxic effects on melanocytes, Oligopeptide-34 acts through a targeted, multi-level approach that addresses melanin production at both the transcriptional regulation and enzymatic activity stages. This precision targeting makes it a compound of significant research interest in the...
Evidence Summary
Oligopeptide-34 has preliminary preclinical evidence only. Human clinical trial data is not available.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Multi-Level Melanogenesis Modulation | Animal studies |
| Non-Cytotoxic Mechanism | Animal studies |
| Comparable Efficacy to Established Agents | Animal studies |
| Broad Pigmentation Research Applications | Animal studies |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
Editorial Position
Oligopeptide-34 is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Oligopeptide-34 is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Oligopeptide-34 Been Studied For?
Research areas where Oligopeptide-34 has been investigated in published studies
-
Multi-Level Melanogenesis Modulation Oligopeptide-34 has been studied in animal models of multi-level melanogenesis modulation. These findings have not been confirmed in controlled human trials.
-
Non-Cytotoxic Mechanism Oligopeptide-34 has been studied in animal models of non-cytotoxic mechanism. These findings have not been confirmed in controlled human trials.
-
Comparable Efficacy to Established Agents Oligopeptide-34 has been studied in animal models of comparable efficacy to established agents. These findings have not been confirmed in controlled human trials.
-
Broad Pigmentation Research Applications Oligopeptide-34 has been studied in animal models of broad pigmentation research applications. These findings have not been confirmed in controlled human trials.
How Does Oligopeptide-34 Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 MITF Transcriptional Suppression
- 02 Melanogenic Enzyme Downregulation
- 03 Direct Tyrosinase Competitive Inhibition
- 04 Melanosome Transfer Modulation
Not sure if Oligopeptide-34 is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Oligopeptide-34.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Oligopeptide-34
How Is Oligopeptide-34 Administered?
Oligopeptide-34 is available via Topical application. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Oligopeptide-34?
What Conditions Has Oligopeptide-34 Been Linked To?
Have Questions About Oligopeptide-34?
Published studies on Oligopeptide-34 can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Oligopeptide-34 is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
A qualified specialist experienced with peptide therapies can help you understand the current evidence and determine suitability.
Ready to discuss Oligopeptide-34 with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026